|Videos|November 5, 2020
Fragile X Syndrome
Author(s)Elizabeth Berry-Kravis, MD, PhD
Fragile X syndrome is one of the most common inherited causes of intellectual disability, right below Down syndrome. How are basic science findings being translated into treatments for patients with neurodevelopment disorders, like Fragile X syndrome?
Advertisement
Tetra Therapeutics recently announced positive results from its Phase II exploratory study in adult patients with Fragile X syndrome.
But what is Fragile X syndrome, and what other research has been conducted around this neurodevelopmental disorder?
Elizabeth Berry-Kravis, MD, PhD, explains.
Dr Berry-Kravis is a pediatric neurologist at Rush University Medical Center.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
A New Mechanism for ADHD: Raman Baweja, MD, on Centanafadine's FDA Approval
2
What's New in Psychiatric Treatment? Highlights From the 2026 Southern California Psychiatry Conference
3
A Preventive Window In Post-TBI Care and Subsequent Alzheimer Pathology
4
PET Imaging Confirms Lower Muscarinic M1 Receptor Availability in Schizophrenia
5